Episode 2: Fighting AML in Young Patients: New Research & the Future of CAR-T

Posted on: Apr 28, 2025

Play Episode

Also available on

Overview

This podcast episode discusses the complexities of treating pediatric acute myeloid leukemia (AML) and the potential of CAR-T therapy as a treatment option. Dr. Emily Shea shares insights on the unique challenges faced by pediatric patients, the current research landscape, and the importance of clinical trials. The conversation emphasizes the need for targeted therapies and the significance of patient advocacy in advancing treatment options for this vulnerable population.

On this episode

Mary Arnett

Mary joined HealthTree in 2022 as a part of HealthTree's team to help expand into all blood cancers. She now works as HealthTree's Volunteer & Community Outreach Manager, helping to engage and involve community members in HealthTree's mission. When she isn't working, she loves being the fun aunt to her 13 nieces and nephews, attending concerts, experimenting with new recipes in the kitchen, and traveling to explore new cities.

Dr. Emily Hsieh

Dr. Hsieh is a hematologist oncologist out of the Children's Hospital of Los Angeles. Her research focuses on developing cellular therapy clinical trials for relapsed hematologic malignancies.

Transcript

Episode 2: Fighting AML in Young Patients: New Research & the Future of CAR-T

Episode 2: Fighting AML in Young Patients: New Research & the Future of CAR-T

Related Content